Cargando…

Hypoxia and fibrosis in chronic kidney disease: crossing at pericytes

Chronic kidney disease (CKD) is placing an increasing burden on patients and societies because no decisive therapy has been established. Tubulointerstitial lesions accompanied by fibrosis, inflammatory cells, and capillary rarefaction not only characterize, but also aggravate renal dysfunction in CK...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kawakami, Takahisa, Mimura, Imari, Shoji, Kumi, Tanaka, Tetsuhiro, Nangaku, Masaomi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2014
Materias:	Mini Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4220514/ https://www.ncbi.nlm.nih.gov/pubmed/25401039 http://dx.doi.org/10.1038/kisup.2014.20

Ejemplares similares

Treatment of Diabetic Kidney Disease: Current and Future
por: Yamazaki, Tomotaka, et al.
Publicado: (2021)

Dznep, a histone modification inhibitor, inhibits HIF1α binding to TIMP2 gene and suppresses TIMP2 expression under hypoxia
por: Yamazaki, Tomotaka, et al.
Publicado: (2023)

Genome-wide analysis revealed that DZNep reduces tubulointerstitial fibrosis via down-regulation of pro-fibrotic genes
por: Mimura, Imari, et al.
Publicado: (2018)

Mechanisms of metabolic memory and renal hypoxia as a therapeutic target in diabetic kidney disease
por: Hirakawa, Yosuke, et al.
Publicado: (2017)

Novel lnc RNA regulated by HIF‐1 inhibits apoptotic cell death in the renal tubular epithelial cells under hypoxia
por: Mimura, Imari, et al.
Publicado: (2017)

Recent advances in understanding of chronic kidney disease
por: Yamaguchi, Junna, et al.
Publicado: (2015)

Profile of Daprodustat in the Treatment of Renal Anemia Due to Chronic Kidney Disease
por: Ishii, Taisuke, et al.
Publicado: (2021)

Epigenetic memory contributing to the pathogenesis of AKI-to-CKD transition
por: Tanemoto, Fumiaki, et al.
Publicado: (2022)

Renal Hypoxia in CKD; Pathophysiology and Detecting Methods
por: Hirakawa, Yosuke, et al.
Publicado: (2017)

Effect of M2-like macrophages of the injured-kidney cortex on kidney cancer progression
por: Ishii, Taisuke, et al.
Publicado: (2022)

Exploring molecular targets in diabetic kidney disease
por: Maruno, Sayako, et al.
Publicado: (2022)

Chromatin remodeling factor, INO80, inhibits PMAIP1 in renal tubular cells via exchange of histone variant H2A.Z. for H2A
por: Miura, Rika, et al.
Publicado: (2023)

Inflammation and hypoxia linked to renal injury by CCAAT/enhancer-binding protein δ
por: Yamaguchi, Junna, et al.
Publicado: (2015)

Pericytes in the infarcted heart
por: Alex, Linda, et al.
Publicado: (2019)

Lung pericytes as mediators of inflammation
por: Rayner, Samuel G., et al.
Publicado: (2023)

Epigenetic roles in clonal hematopoiesis and aging kidney-related chronic kidney disease
por: Ogura, Yoshiyasu, et al.
Publicado: (2023)

Therapies Targeting Epigenetic Alterations in Acute Kidney Injury-to-Chronic Kidney Disease Transition
por: Tanemoto, Fumiaki, et al.
Publicado: (2022)

Obesity, oxidative stress, and fibrosis in chronic kidney disease
por: Sharma, Kumar
Publicado: (2014)

Persistent expression of neutrophil gelatinase‐associated lipocalin and M2 macrophage markers and chronic fibrosis after acute kidney injury
por: Saito, Hisako, et al.
Publicado: (2018)

Recent advances in renal regeneration
por: Hasegawa, Sho, et al.
Publicado: (2019)

A distinctive distribution of hypoxia‐inducible factor‐1α in cultured renal tubular cells with hypoperfusion simulated by coverslip placement
por: Honda, Tomoko, et al.
Publicado: (2020)

Safety and effectiveness of long-term use of darbepoetin alfa in non-dialysis patients with chronic kidney disease: a post-marketing surveillance study in Japan
por: Tanaka, Tetsuhiro, et al.
Publicado: (2018)

Biomarkers in kidney fibrosis: are they useful?
por: Wong, Muh Geot, et al.
Publicado: (2014)

Acetate attenuates kidney fibrosis in an oxidative stress‐dependent manner
por: Kawabata, Chiaki, et al.
Publicado: (2023)

The role of oxidative stress and hypoxia in renal disease
por: Honda, Tomoko, et al.
Publicado: (2019)

Role of HIPK2 in kidney fibrosis
por: Fan, Ying, et al.
Publicado: (2014)

Wnt/β-catenin signaling and kidney fibrosis
por: Tan, Roderick J, et al.
Publicado: (2014)

Overview of the cellular and molecular basis of kidney fibrosis
por: Eddy, Allison A
Publicado: (2014)

New measures against chronic kidney diseases in Japan since 2018
por: Fukui, Akira, et al.
Publicado: (2019)

Thyroid hormone increases oxygen metabolism causing intrarenal tissue hypoxia; a pathway to kidney disease
por: Sivertsson, Ebba, et al.
Publicado: (2022)

eGFR slope as a surrogate endpoint for clinical study in early stage of chronic kidney disease: from The Japan Chronic Kidney Disease Database
por: Itano, Seiji, et al.
Publicado: (2023)

Kick it up a notch: Notch signaling and kidney fibrosis
por: Sweetwyne, Mariya T, et al.
Publicado: (2014)

Nutcracker Syndrome with the Superimposition of Thin Basement Membrane Syndrome
por: Hirakawa, Yosuke, et al.
Publicado: (2018)

Adipose tissue metabolic changes in chronic kidney disease
por: Serrano, Eurico, et al.
Publicado: (2023)

Molecular Regulation of the Response of Brain Pericytes to Hypoxia
por: Carlsson, Robert, et al.
Publicado: (2023)

Quantitating intracellular oxygen tension in vivo by phosphorescence lifetime measurement
por: Hirakawa, Yosuke, et al.
Publicado: (2015)

Paricalcitol Improves Hypoxia-Induced and TGF-β1-Induced Injury in Kidney Pericytes
por: Lim, Jeong-Hoon, et al.
Publicado: (2021)

Microvascular pericytes in healthy and diseased kidneys
por: Pan, Szu-Yu, et al.
Publicado: (2014)

Nutrition care for chronic kidney disease during pregnancy: an updated review
por: Reyes-López, María Angélica, et al.
Publicado: (2020)

How FGF23 shapes multiple organs in chronic kidney disease
por: Leifheit-Nestler, Maren, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3tjhuph5uhfjpr3vlpnildi777